Generic Rx Products
Nucrogene develops products with focus on wide range of therapeutic areas including, cardiovascular, proton pump inhibitors, anti-infection and anti-inflammatory diseases and other medical conditions in the United States, Europe and international market. Dosage forms include immediate release (IR), extended release(ER), delayed release(DR) tablets, capsules, liquids, suspensions, injectable and transdermal.
Value of Innovation
Innovation leads to the discovery and development of new products that save and extend lives — the primary goal of any healthcare program.
Patients Health
Underlying our commitment is a proven dedication to changing the course of human health through bold pursuits in science and transformational medicines.
Corporate Responsibility
We promise to always put patients first, by ensuring that patients have safe, well controlled access to life-enhancing therapies and by improving patient care globally through education, innovation and bold pursuits in science.